Osaka, Japan

Atsushi Moroda

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Atsushi Moroda: Innovator in Pharmaceutical Chemistry

Introduction

Atsushi Moroda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing valuable compounds. With a total of 2 patents to his name, Moroda's work is recognized for its industrial advantages and safety considerations.

Latest Patents

Moroda's latest patents focus on a method for producing a 1,4-benzoxazine compound. This compound is useful in the medical field, and the method he developed aims to avoid safety and health risks. The process involves three key steps: converting the amino group at the 7-position in a specific compound into a dimesylamino group, coupling another compound with a boronic acid compound, and finally converting the 7-position in a subsequent compound into a monomesylamino group. This innovative approach highlights Moroda's commitment to advancing pharmaceutical manufacturing techniques.

Career Highlights

Atsushi Moroda is currently employed at Mitsubishi Tanabe Pharma Corporation, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also enhanced the safety and efficacy of medicinal compounds.

Collaborations

Throughout his career, Moroda has collaborated with notable colleagues, including Tomoyuki Okabe and Takeshi Hamada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Atsushi Moroda's contributions to pharmaceutical chemistry exemplify the importance of innovation in medicine. His patents and collaborative efforts reflect a dedication to improving health outcomes through safer and more effective production methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…